Evidence map›Paper›PMID 27171861›Full record

ArticleMacromolecular bioscience2016

Polymerizing Insulin with Photocleavable Linkers to Make Light-Sensitive Macropolymer Depot Materials.

Bhagyesh R Sarode, Piyush K Jain, Simon H Friedman

Open access · greenAbstract read
In one paragraph

Article in Macromolecular bioscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Light Activated Glucagon Trimer with Resistance to Fibrillation.ACS biomaterials science & engineering · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bhagyesh R SarodeDivision of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, MO, 64108, USA.
Piyush K JainDivision of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, MO, 64108, USA.
Simon H FriedmanDivision of Pharmaceutical Sciences, University of Missouri-Kansas City, Kansas City, MO, 64108, USA.
University of Missouri–Kansas City · US

Funding

Cannula-free and pump-free delivery of insulin using lightDP3DK106921 · NIDDK · UNIVERSITY OF MISSOURI KANSAS CITY · PI FRIEDMAN, SIMON H · 2015 to 2015
$1.4M
NIDDK NIH HHS DP3 DK106921
6 · The paper itself

Abstract

The use of light-sensitive polymers for the release of therapeutics is an important approach allowing the timing and amount of the release to be controlled precisely. The use of light has been pioneered to control insulin release from a dermal photoactivated depot, or PAD. One of the main impediments to the use of light-sensitive polymers in this context is the density of the materials: The large majority of the material is the carrier polymer, with the minority being the therapeutic. In this work, the feasibility of using insulin itself as a monomer in the polymerization process is demonstrated. Insulin modified with either one or two light cleavable azide groups is polymerized with a tridentate alkyne-bridging monomer using a click reaction. The resulting material called a "macropolymer" is ≈85% insulin, is insoluble in aqueous solvent, and releases native, soluble insulin upon irradiation.

Indexed as

LightPolymerizationDimethyl SulfoxideEnzyme-Linked Immunosorbent AssayHumansInsulinKineticsPhotolysisPolymersDimethyl SulfoxideInsulinPolymersclick reactiondepotinsulinphotoactivation

Identifiers

PMID27171861
PMCPMC5081178
OpenAlexW2378010840

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.